ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

The Financial Impact of the Opioid Epidemic on Kidney Transplantation Readmissions

L. Wilson, D. Taber, N. Pilch, R. Gilbert, Z. Elmaasarani, B. O'Brien, N. Patel, P. Mauldin, S. Ball, P. Baliga, J. Fleming.

MUSC, Charleston, SC.

Meeting: 2018 American Transplant Congress

Abstract number: 366

Keywords: Economics, Kidney transplantation, Resource utilization

Session Information

Date: Monday, June 4, 2018

Session Name: Concurrent Session: Non-Organ Specific: Economics, Public Policy, Allocation, Ethics - 1

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:54pm-5:06pm

Location: Room 4C-4

Related Abstracts
  • Resource Utilization and Cost Analysis of Early Hospital Readmissions Following Kidney Transplantation.
  • Comparing the Role of Post-Transplant Readmissions and Bed Days on Total One Year Cost of Care.

Research has demonstrated increased annual medical costs in patients who abuse opioids, estimated at up to $18,000 per patient and $29 billion overall in the US. Our aim was to evaluate the financial impact of any pre-transplant opioid use on readmission costs in kidney transplants.

Methods:

Retrospective, single center analysis evaluating kidney transplants between 1/2010 and 12/2016. Opioid use was defined as an opioid reported during medication reconciliation at the time of transplant or opioid prescription within 3 months from a national pharmacy claims database. Costs were adjusted to 2016 values utilizing a 3% average inflation rate per year.

Results:

Out of 1,129 kidney transplants, 271 (24%) were opioid experienced (OE) and 858 (76%) were opioid naïve (ON). Patients that were OE were more likely to be white, more highly sensitized, and had more baseline benzodiazepine use (Table 1). There were no differences between cohorts in LOS, cost of transplant hospitalization, or rejection rates. The number of readmissions for patients in each cohort can be visualized in Figure 1. OE patients demonstrated significantly more readmissions and a significantly higher mean total cost of readmissions at 30-, 90-, and 365-days after transplant (Table 2).

Conclusion:

Pre-transplant opioid use is significantly associated with increased costs associated with readmissions in the year after kidney transplantation. Causes and preventability of readmissions should be further explored.

CITATION INFORMATION: Wilson L., Taber D., Pilch N., Gilbert R., Elmaasarani Z., O'Brien B., Patel N., Mauldin P., Ball S., Baliga P., Fleming J. The Financial Impact of the Opioid Epidemic on Kidney Transplantation Readmissions Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Wilson L, Taber D, Pilch N, Gilbert R, Elmaasarani Z, O'Brien B, Patel N, Mauldin P, Ball S, Baliga P, Fleming J. The Financial Impact of the Opioid Epidemic on Kidney Transplantation Readmissions [abstract]. https://atcmeetingabstracts.com/abstract/the-financial-impact-of-the-opioid-epidemic-on-kidney-transplantation-readmissions/. Accessed March 8, 2021.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.